Resources

HMT News & Press Releases, Useful Links, Pathway Maps, Videos, Publications & more.

Published in Psychiatry and Clinical Neurosciences

The First diagnostic plasma metabolite biomarker for Major Depression Disorder (MDD) has been published in Psychiatry and Clinical Neurosciences.

Download Press Release

HMT and Toyobo and MDD

HMT and Toyobo have established production of Ethanolaminephosphate phospho-lyase for clinical assay relating Major Depression Disorder (MDD).

Download Press Release

HMT signed a Licensing Agreement with Sysmex Corporation for Biomarker Kit for Depressive Disorder

HMT has researched and developed a blood
biomarker for Depressive Disorder in cooperation with
National Center of Neurology and Psychiatry and GYOKIKAI Medical Corporation.

Download Press Release

HMT hires Alexander Buko Ph.D. as Vice President

HMT hires Alexander Buko Ph.D. as Vice
President, Business and Product Development and releases a new C13 flux analysis service, F-SCOPE.

Download Press Release

HMT Expands to U.S.

Proximity to world‐class institutions and pharmaceutical companies for cancer and biomarker research makes Cambridge the top choice for HMT.

Download Press Release

Back to Top